Improved levothyroxine pharmacokinetics after bariatric surgery

Thyroid

Volumn 23, Issue 4, 2013, Pages 414-419

  Gkotsina, Margarita ^a   Michalaki, Marina ^a   Mamali, Irene ^a   Markantes, Georgios ^a   Sakellaropoulos, George C ^a   Kalfarentzos, Fotios ^a   Vagenakis, Apostolos G ^a   Markou, Kostas B ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; ANTIBODY BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG ABSORPTION; HUMAN; LIOTHYRONINE BLOOD LEVEL; MAXIMUM PLASMA CONCENTRATION; OBESITY; PRIORITY JOURNAL; REPEAT PROCEDURE; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; STOMACH BYPASS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADOLESCENT; ADULT; BARIATRIC SURGERY; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; THYROID HORMONES; THYROXINE; TREATMENT OUTCOME;

EID: 84875726510     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0526     Document Type: Article

References (33)

1. Devdhar M, Drooger R, Pehlivanova M, Singh G, Jonklaas J 2011 Levothyroxine replacement doses are affected by gender and weight, but not age. Thyroid 21:821-827.
2. Liwanpo L, Hershman JM 2009 Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab 23:781-792.
3. McDermott JH, Coss A, Walsh CH 2005 Celiac disease presenting as resistant hypothyroidism. Thyroid 15:386-388.
4. Centanni M, Gargano L, Canettieri G, Viceconti N, Franchi A, Delle Fave G, Annibale B 2006 Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med 354:1787-1795.
5. Hays MT, Nielsen KR 1994 Human thyroxine absorption: age effects and methodological analyses. Thyroid 4:55-64.
6. Liel Y, Harman-Boehm I, Shany S 1996 Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients. J Clin Endocrinol Metab 81:857-859.
7. Hays MT 1991 Localization of human thyroxine absorption. Thyroid 1:241-248.
8. Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C; Endocrine Society 2010 Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 95:4823-4843.
9. Steinbrook R 2004 Surgery for severe obesity. N Engl J Med 350:1075-1079.
10. Santini F, Pinchera A, Marsili A, Ceccarini G, Castagna MG, Valeriano R, Giannetti M, Taddei D, Centoni R, Scartabelli G, Rago T, Mammoli C, Elisei R, Vitti P 2005 Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab 90:124-127.
11. Michalaki MA, Gkotsina MI, Mamali I, Markantes GK, Faltaka A, Kalfarentzos F, Vagenakis AG, Markou KB 2011 Impaired pharmacokinetics of levothyroxine in severely obese volunteers. Thyroid 21:477-481.
12. Azizi F, Belur R, Albano J 1979 Malabsorption of thyroid hormones after jejunoileal bypass for obesity. Ann Intern Med 90:941-942.
13. Topliss DJ, Wright JA, Volpe R 1980 Increased requirement for thyroid hormone after a jejunoileal bypass operation. Can Med Assoc J 123:765-766.
14. Skroubis G, Karamanakos S, Sakellaropoulos G, Panagopoulos K, Kalfarentzos F 2011 Comparison of early and late complications after various bariatric procedures: incidence and treatment during 15 years at a single institution. World J Surg 35:93-101.
15. INc FC 2003 Approved Drug Products with Therapeutic Equivalence Evaluations. In: www.fda.gov/cder/ob/docs/preface/ecpreface (accessed September 29, 2003).
16. Blakesley V, Awni W, Locke C, Ludden T, Granneman GR, Braverman LE 2004 Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable? Thyroid 14:191-200.
17. Eisenberg M, Samuels M, DiStefano JJ 2006 L-T4 bioequivalence and hormone replacement studies via feedback control simulations. Thyroid 16:1279-1292.
18. Blakesley VA 2005 Current methodology to assess bioequivalence of levothyroxine sodium products is inadequate. AAPS J 7:E42-46.
19. Lemmens HJ, Bernstein DP, Brodsky JB 2006 Estimating blood volume in obese and morbidly obese patients. Obes Surg 16:773-776.
20. Rubio IG, Galrao AL, Santo MA, Zanini AC, Medeiros-Neto G 2012 Levothyroxine absorption in morbidly obese patients before and after Roux-en-Y gastric bypass (RYGB) surgery. Obes Surg 22:253-258.
21. Herz R Jr, Tapley DF, Ross JE 1961 Glucuronide formation in the transport of thyroxine analogues by rat intestine. Biochim Biophys Acta 53:273-284.
22. Barter RA, Klaassen CD 1994 Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP- glucuronosyltransferase inducers in rats. Toxicol Appl Pharmacol 128:9-17.
23. Hood A, Klaassen CD 2000 Differential effects of microsomal enzyme inducers on in vitro thyroxine (T(4)) and triiodothyronine (T(3)) glucuronidation. Toxicol Sci 55: 78-84.
24. Wu SY, Green WL, Huang WS, Hays MT, Chopra IJ 2005 Alternate pathways of thyroid hormone metabolism. Thyroid 15:943-958.
25. Spak E, Bjorklund P, Helander HF, Vieth M, Olbers T, Casselbrant A, Lonroth H, Fandriks L 2010 Changes in the mucosa of the Roux-limb after gastric bypass surgery. Histopathology 57:680-688.
26. Zhang H, DiBaise JK, Zuccolo A, Li W, Zheng RB, Ling CC 2009 Human gut microbiota in obesity and after gastric bypass. PNAS 16:2365-2370.
27. Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, Bouillot JL, Mariat D, Corthier G, Doré J, Henegar C, Rizkalla S, Cle'ment K 2010 Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss. Diabetes 59:3049- 3057.
28. Pabla D, Akhlaghi F, Zia H 2009 A comparative pHdissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry. Eur J Pharm Biopharm 72:105-110.
29. Hays MT, Katz L 1973 Thyroxine (T4) absorption in small intestinal disease. J Nucl Med 14:406-407.
30. Hays MT 1968 Absorption of oral thyroxine in man. J Clin Endocrinol Metab 28:749-756.
31. Boelen A, Wiersinga WM, Fliers E 2008 Fasting-induced changes in the hypothalamus-ituitary-thyroid axis. Thyroid 18:123-129.
32. Warner MH, Beckett GJ 2010 Mechanisms behind the nonthyroidal illness syndrome: an update. J Endocrinol 205: 1-13.
33. Vagenakis AG, Burger A, Portnary GI, Rudolph M, O'Brian JR, Azizi F, Arky RA, Nicod P, Ingbar SH, Braverman LE 1975 Diversion of peripheral thyroxine metabolism from activating to inactivating pathways during complete fasting. J Clin Endocrinol Metab 41:191-194.